GURUFOCUS.COM » STOCK LIST » Technology » Software » Neurones (XPAR:NRO) » Definitions » Change In Receivables

Neurones (XPAR:NRO) Change In Receivables : €0.0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Neurones Change In Receivables?

Neurones's change in receivables for the quarter that ended in Dec. 2023 was €0.0 Mil. It means Neurones's Accounts Receivable stayed the same from Jun. 2023 to Dec. 2023 .

Neurones's change in receivables for the fiscal year that ended in Dec. 2023 was €0.0 Mil. It means Neurones's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

Neurones's Accounts Receivable for the quarter that ended in Dec. 2023 was €175.1 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Neurones's Days Sales Outstanding for the six months ended in Dec. 2023 was 85.81.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Neurones's liquidation value for the six months ended in Dec. 2023 was €163.1 Mil.


Neurones Change In Receivables Historical Data

The historical data trend for Neurones's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurones Change In Receivables Chart

Neurones Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Neurones Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Neurones Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurones  (XPAR:NRO) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Neurones's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=175.134/372.483*91
=85.81

2. In Ben Graham's calculation of liquidation value, Neurones's accounts receivable are only considered to be worth 75% of book value:

Neurones's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=297.758-266.344+0.75 * 175.134+0.5 * 0.709
=163.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurones Change In Receivables Related Terms

Thank you for viewing the detailed overview of Neurones's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurones (XPAR:NRO) Business Description

Industry
Traded in Other Exchanges
Address
Immeuble Le Clemenceau 1 - 205, Avenue Georges Clemenceau, Nanterre Cedex, Paris, FRA, 92024
Neurones SA is a France-based technology sector company. Its core business involves the provision of Information Technology (IT) services catering to the needs of hardware, software, and consulting. Its operations are thereby divided into three segments: Infrastructure Services, Application Services, and Consulting. The Infrastructure segment is the strongest revenue driver through the provision of such services as IT operations, IT service management, systems and network, server, application, and workstation outsourcing. Its second most profitable business is carried out through the Application segment, which entails SAP, Web and decision support, social media, data analysis.